7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: A randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers

      , , ,
      Clinical Therapeutics
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Rebamipide is a quinolinone-derived gastroprotective agent approved in Korea for the treatment of gastric ulcers, acute gastritis, and exacerbated chronic gastritis.

          Related collections

          Author and article information

          Journal
          Clinical Therapeutics
          Clinical Therapeutics
          Elsevier BV
          01492918
          November 2009
          November 2009
          : 31
          : 11
          : 2712-2721
          Article
          10.1016/j.clinthera.2009.11.010
          20110013
          8d5d43c9-3920-422a-ac4d-6b1a841e7a2a
          © 2009

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article